# Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/biosimilar-pegfilgrastim-may-offer-affordable-treatment-options-for-patients-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jingyan Yang,Rongzhe Liu,A. Granghaud,Omer Zaidi,Jennifer Stephens |
| Citations | 10 |
| DOI | 10.1080/13696998.2021.1922252 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://www.tandfonline.com/doi/pdf/10.1080/13696998.2021.1922252?needAccess=true |
| OpenAlex ID | https://openalex.org/W3157708932 |
| PMID | 33904357 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Omer Zaidi](https://scholariq.org/researchers/omer-zaidi/)

## Paper journal

- [Journal of Medical Economics](https://scholariq.org/journals/journal-of-medical-economics/)

## Paper primary topic

- [Neutropenia and Cancer Infections](https://scholariq.org/topics/neutropenia-and-cancer-infections/)

## Paper topics

- [Neutropenia and Cancer Infections](https://scholariq.org/topics/neutropenia-and-cancer-infections/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Blood disorders and treatments](https://scholariq.org/topics/blood-disorders-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.